Cargando…

P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS

Detalles Bibliográficos
Autores principales: Bamford, Rebecca, Maleki-Toyserkani, Shayda, Taverner, Will, Freedman, Josh, Hayman, Matt, Saini, Manoj, Gooding, Sarah, Ramasamy, Karthik, Fisher, Kerry, Duffy, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430607/
http://dx.doi.org/10.1097/01.HS9.0000972336.33493.9c
_version_ 1785091005975887872
author Bamford, Rebecca
Maleki-Toyserkani, Shayda
Taverner, Will
Freedman, Josh
Hayman, Matt
Saini, Manoj
Gooding, Sarah
Ramasamy, Karthik
Fisher, Kerry
Duffy, Margaret
author_facet Bamford, Rebecca
Maleki-Toyserkani, Shayda
Taverner, Will
Freedman, Josh
Hayman, Matt
Saini, Manoj
Gooding, Sarah
Ramasamy, Karthik
Fisher, Kerry
Duffy, Margaret
author_sort Bamford, Rebecca
collection PubMed
description
format Online
Article
Text
id pubmed-10430607
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104306072023-08-17 P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS Bamford, Rebecca Maleki-Toyserkani, Shayda Taverner, Will Freedman, Josh Hayman, Matt Saini, Manoj Gooding, Sarah Ramasamy, Karthik Fisher, Kerry Duffy, Margaret Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430607/ http://dx.doi.org/10.1097/01.HS9.0000972336.33493.9c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Bamford, Rebecca
Maleki-Toyserkani, Shayda
Taverner, Will
Freedman, Josh
Hayman, Matt
Saini, Manoj
Gooding, Sarah
Ramasamy, Karthik
Fisher, Kerry
Duffy, Margaret
P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS
title P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS
title_full P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS
title_fullStr P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS
title_full_unstemmed P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS
title_short P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS
title_sort p1362: development of a novel oncolytic virus -theo-310 - specialised for targeting the bone marrow tumour microenvironment of multiple myeloma patients
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430607/
http://dx.doi.org/10.1097/01.HS9.0000972336.33493.9c
work_keys_str_mv AT bamfordrebecca p1362developmentofanoveloncolyticvirustheo310specialisedfortargetingthebonemarrowtumourmicroenvironmentofmultiplemyelomapatients
AT malekitoyserkanishayda p1362developmentofanoveloncolyticvirustheo310specialisedfortargetingthebonemarrowtumourmicroenvironmentofmultiplemyelomapatients
AT tavernerwill p1362developmentofanoveloncolyticvirustheo310specialisedfortargetingthebonemarrowtumourmicroenvironmentofmultiplemyelomapatients
AT freedmanjosh p1362developmentofanoveloncolyticvirustheo310specialisedfortargetingthebonemarrowtumourmicroenvironmentofmultiplemyelomapatients
AT haymanmatt p1362developmentofanoveloncolyticvirustheo310specialisedfortargetingthebonemarrowtumourmicroenvironmentofmultiplemyelomapatients
AT sainimanoj p1362developmentofanoveloncolyticvirustheo310specialisedfortargetingthebonemarrowtumourmicroenvironmentofmultiplemyelomapatients
AT goodingsarah p1362developmentofanoveloncolyticvirustheo310specialisedfortargetingthebonemarrowtumourmicroenvironmentofmultiplemyelomapatients
AT ramasamykarthik p1362developmentofanoveloncolyticvirustheo310specialisedfortargetingthebonemarrowtumourmicroenvironmentofmultiplemyelomapatients
AT fisherkerry p1362developmentofanoveloncolyticvirustheo310specialisedfortargetingthebonemarrowtumourmicroenvironmentofmultiplemyelomapatients
AT duffymargaret p1362developmentofanoveloncolyticvirustheo310specialisedfortargetingthebonemarrowtumourmicroenvironmentofmultiplemyelomapatients